LabViews Newsletter October 2008
Biomarkers Europe
Nov. 10 - 11, 2008
InterContinental Wien
Vienna, Austria
DIA 3rd Annual Cardiac Safety Conference
Dec. 4 - 5, 2008
Hotel Hilton
Barcelona, Spain
CBI 3rd Annual Cardiac Safety Assessment Summit
Jan. 12 - 12, 2009
Sheraton Premiere
Vienna, VA
IIR 7th Annual Partnering with Central Labs, EDC and Imaging Labs
Jan. 26 - 28, 2009
Red Rock Resort
Las Vegas, NV
Biomarker Assay Development
Jan. 26 - 28, 2009
Westin San Diego
San Diego, CA
CBI 6th Annual Medical Imaging for Clinical Trials
Feb. 26 - 27, 2009
Washington, DC
Contact Us
Click here to contact Marissa Shapiro, assistant editor.
Click here to learn about direct mail opportunities.
Click here to learn about reprints of Applied Clinical Trials.
ADVERTISMENT
i3
i3 is one of the world’s leading providers of specialized pharmaceutical services, delivering integrated scientific strategies and solutions throughout the product lifecycle. At any point from development to market, anywhere you need to be, we deliver specialization and scientific depth for your most intricate challenges. Look to us to see all the possibilities.
Learn how Cardiac Safety strategies can protect drug research program. Web-Seminar: “Leveraging a Multiphase QT Strategy to Expedite Development and Reduce Investment Risk” on Wednesday, November 5th, 2008, from 11:00am - 12:30pm EST.
For 25 years, IBT Laboratories has provided the broadest range of allergy and immunological tests available from a single provider to complement pharmaceutical product development.
EXPeRT® ePRO – Simplified. Delivered. Guaranteed. Trust your patient reported outcomes with eRT, an industry-leading clinical technology provider.
You are subscribed to apct_enews_labviews as [email protected] To unsubscribe from this list click here.To ensure delivery to your Inbox, please add [email protected] to your address book. If you need help doing this, click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
